Bioject, Elan deal

The companies formed a Portland-based joint venture to develop and commercialize a continuous glucose monitoring system for diabetics.

Read the full 189 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE